alexa Recent Treatments For Cardiac Arrhythmias: Confusion Of Ganglionated Plexi (GP), Fibrosis And Myocardial Structural Diseases Areas, Leading To Similarity Of Detected Signals (complex Atrial Fractionated Electrograms)
ISSN: 2329-6895

Journal of Neurological Disorders
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd International Conference on Neuroimmunology & Therapeutics
December 01-02, 2016 Atlanta, USA

Marc Mounir Rahme
Ottawa University, USA
Posters & Accepted Abstracts: J Neurol Disord
DOI: 10.4172/2329-6895.C1.015
Abstract
Atrial Fibrillation (AF) is a major life threatening disease which is still refractory to all pharmaceutical compounds. Catheter ablation procedure is currently used as an ‘easy and safe’ clinical intervention targeting the early activation sites that are triggering the initiation of arrhythmias. However, the catheter ablation procedure is still considered as ineffective treatment for long-term curing of arrhythmias and for preventing their recurrences. Despite the high technologies for mapping, detecting and delivering the right energy sources to any location in the human cardiac heart chambers insulating the right triggers areas for AF still the main challenges to all currently existing devices companies (ex. Biosense Webster (subsidiary of J&J; Carto Solution), St Jude Medical Inc, (Ensite system), Boston Scientific, Medtronic (with Cryocath Technologies, Atricure Inc, etc). Detecting the sites of early activations and the locations of the triggers ganglia are still confused with other structural diseases such as fibrosis, which are limiting those devices to achieve the detection of the right hit (ex. triggering GP). Thus, it adds complications and risks to the long-term inefficacy of the catheter ablation procedure, in addition to major side effects and complications to this minimally invasive clinical procedure. ‘NerveC’ is developing a high end assembly able to detect selectively the GPlocations. Thus, it will limit the confusion during mapping of the heart for electrophysiological (EP) study and for catheter ablation procedure for offering long-term cure from cardiac arrhythmias, such as atrial fibrillation, a major disease that affects our aging population. Therefore, by introducing ‘NerveC’ to the EP clinical practice will help to detect selective EP signals generated by the autonomic nerve (=GP) using the FFT (Fast Fourier Transformation), offering a unique method to specifically targeting the rotors triggering the cardiac AF.
Biography

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords